Skip to content
healthcare.dev

LYVISPAH

NDC 87519-003, baclofen, granule, from Anvi Pharmaceuticals Inc.

Product NDC
87519-003
Status
Listed
Labeler
Anvi Pharmaceuticals Inc
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215422
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87519-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BACLOFEN10 mg/1

Pharmacologic classes

GABA A Agonists [MoA]; GABA B Agonists [MoA]; gamma-Aminobutyric Acid-ergic Agonist [EPC]

Package NDCNDC-11Package
87519-003-908751900039090 PACKET in 1 CARTON (87519-003-90) / 1 GRANULE in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5b13c40d-a109-f838-e063-6294a90aecf2

Use it

Look up 87519-003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87519-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87519-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.